Peer-influenced content. Sources you trust. No registration required. This is HCN.
Mayo Clinic
The 2024 HCM guideline introduces cardiac myosin inhibitors as a new therapeutic option and relaxes exercise restrictions, potentially altering the landscape of HCM management.
Cardiology July 22nd 2024
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH